Fei Sa

438 total citations
9 papers, 377 citations indexed

About

Fei Sa is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, Fei Sa has authored 9 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Pharmacology. Recurrent topics in Fei Sa's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Traditional Chinese Medicine Analysis (2 papers). Fei Sa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Traditional Chinese Medicine Analysis (2 papers). Fei Sa collaborates with scholars based in Macao, Hong Kong and China. Fei Sa's co-authors include Simon Ming‐Yuen Lee, Maggie Pui Man Hoi, Ying Zheng, Zhong-Yan Zhou, Yitao Wang, Kwok‐Pui Fung, Jian‐Li Gao, Sai Li, Cheong‐Meng Chong and Valentina Razmovski‐Naumovski and has published in prestigious journals such as Free Radical Biology and Medicine, British Journal of Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Fei Sa

9 papers receiving 371 citations

Peers

Fei Sa
Comparison fields: 5 of 70
  • Molecular Biology 206
  • Neurology 63
  • Cellular and Molecular Neuroscience 61
  • Complementary and alternative medicine 59
  • Neurology 58
Replace Samuel S.W. Szeto with:
Samuel S.W. Szeto Canada
Jarbas Mota Siqueira Brazil
Hoon Jae Jeong South Korea
Hefeng Zhou China
Nikolaos Stavros Koulakiotis Greece
Liangfeng Liu Hong Kong
Xiaoqin Cheng China
Nishant Saxena United States
E-Jian Lee Taiwan
Sohee Kim United States
Samuel S.W. Szeto Canada View profile →
Citations per field, relative to Fei Sa
Fei Sa · 1×
Citations per year, relative to Fei Sa
Fei Sa · 1×

Countries citing papers authored by Fei Sa

Since Specialization
Citations

This map shows the geographic impact of Fei Sa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Sa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Sa more than expected).

Fields of papers citing papers by Fei Sa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Sa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Sa. The network helps show where Fei Sa may publish in the future.

Co-authorship network of co-authors of Fei Sa

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Sa. A scholar is included among the top collaborators of Fei Sa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Sa. Fei Sa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 39
2 61
3 22
4 19
5 6
6 71
7 55
8 39
9 65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026